|
A.S. Polyakova (1, 2), M.D. Bakradze (1), G.V. Dzhivanshiryan (1), V.K. Tatochenko (1)
Current view of the Epstein–Barr virus infection
|
№10 / 2019
|
|
I.V. Kosova (1, 2), O.B. Loran (1), L.A. Sinyakova (1), L.V. Gundorova (3), V.A. Kosov (4), I.E. Pogodina (5), D.N. Kolbasov (2)
PD-L1 EXPRESSION IN BLADDER CANCER AGAINST THE BACKGROUND OF CHRONIC HERPESVIRUS INFECTION: RESULTS OF A PILOT STUDY
|
№6 / 2018
|
|
O.B. Loran (1), L.A. Sinyakova (1), L.V. Gundorova (2), V.A. Kosov (3), I.V. Kosova (4), I.E. Pogodina (5), D.N. Kolbasov (4)
ONCOMODULATING EFFECT OF CYTOMEGALOVIRUS IN BLADDER CANCER: MYTH OR REALITY?
|
№3 / 2017
|
|
E.B. Belan, T.L. Sadchikova, A.A .Panina, Yu.A. Maldaeva, A.I. Sadchikova
OPTIMIZATION OF THERAPY OF RECURRENT CYTOMEGALOVIRUS- AND EPSTEIN-BARR VIRUS - ASSOCIATED RHINOPHARYNGITIS IN CHILDREN
|
№14 / 2015
|
|
I.P. Baranova (1), D. Yu. Kurmaeva (2), O.N. Lesina (1)
INFECTIOUS MONONUCLEOSIS: CLINICAL MANIFESTATION, DIAGNOSIS, AND TREATMENT WITH RECOMBINANT INTERFERON α-2β
|
№1 / 2014
|
Русский
